| Market Cap | ₹876.19 CrSmall Cap |
|---|---|
| Revenue Growth | 58.07%Qtr YoY |
| Revenue TTM | ₹190.56 CrOperating |
| RSI | 55.74Neutral Zone |
Key highlights
- Introduction of ExoAtlet II wearable robotic suit for lower-limb and gait recovery
- Targeting India's projected senior population of 347 million by the year 2050
- Bengaluru facility upgraded to high-end tier of Indian robotic-assisted care centres
- Specialist-led program directed by Physical Medicine and Rehabilitation doctors
- Dual-robotic approach including specialized devices for hand and finger retraining
The Product — What It Is
ExoAtlet II is a wearable robotic suit designed to facilitate lower-limb and gait recovery through consistent, physiologically accurate steps. It fits around a patient’s legs and hips, enabling high-repetition therapy that is difficult to sustain manually. The technology is paired with a dedicated robotic device for hand and finger retraining at the Bannerghatta centre.
Clinical protocols are directed by specialists in Physical Medicine and Rehabilitation, ensuring that the exoskeleton's settings are calibrated to individual recovery goals for patients suffering from stroke, paralysis, or neurological conditions.
Commercial Opportunity
- Rising demand driven by an estimated 347 million senior citizens in India by 2050
- Stroke identified as a leading cause of adult-onset mobility loss in the domestic market
- Strategic entry into the niche segment of robotic-assisted transition care
- Addressing the functional recovery gap between acute hospital discharge and home care
- Premium service positioning for specialized neurological and orthopaedic rehabilitation
Strategic Fit
The launch strengthens Antara’s specialist-led rehabilitation ecosystem, which operates under the broader Max India portfolio. By incorporating advanced robotics, the company enhances its multidisciplinary care model that spans physiotherapy, occupational therapy, and cognitive care. This move aligns with the group’s focus on high-acuity senior care services, moving beyond traditional residential living into specialized medical interventions.
The Bannerghatta facility now serves as a key pillar in Antara's transition care network, which currently maintains 485 beds across eight facilities in India's major metropolitan hubs.
Business Overview
Founded in 2013, Antara is the senior-care vertical of the 7-billion-dollar Max Group. It operates through two main business lines: Residences for Seniors and Assisted Care Services. The residential portfolio includes an established community in Dehradun and upcoming projects in Noida’s Sector-150 and Gurugram.
The Assisted Care arm includes Care Homes, Care at Home services, and the AGEasy direct-to-consumer brand, which has reportedly impacted over 7 lakh lives since its 2023 launch. The company continues to expand its footprint in Delhi-NCR, Bengaluru, and Chennai to meet increasing demand for professional geriatric care.
“The introduction of ExoAtlet II at the Antara Care Home in Bannerghatta strengthens our rehabilitation and post-operative care ecosystem for neurological, orthopaedic, and geriatric patients, helping them regain functional independence and confidence as they recover.”
“Where robotic-assisted gait training is indicated, the exoskeleton’s settings are calibrated to the individual need and progressed as they improve.”
| Share price | ₹166.63 |
|---|---|
| Market capitalisation | ₹876.19 Cr |
| Revenue (annual) | ₹190.56 Cr |
| Net profit (annual) | -₹121.85 Cr |
| Revenue (latest quarter) | ₹65.63 Cr+52.27% vs previous quarter |
| Net profit (latest quarter) | -₹19.29 Cr+54.98% vs previous quarter |
| P/E (TTM) | -7.19×Sector 25.1× |
| Promoter holding | 49.82%-0.07% QoQ |
| FII holding | 7.07%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Max India Limited announcing the launch of robotic-assisted rehabilitation services by its subsidiary, Antara. Market figures from a third-party data provider.
